Private equity deals in pharmaceutical in Canada remained flat in Q3 2024
In the Canadian pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of…
PE
-
-
Q3 2024 update: artificial intelligence related private equity activity in the pharmaceutical industry
Analysis of the key themes driving private equity deal activity reveals that artificial intelligence accounted for three pharmaceutical deals announced…
-
Q3 2024 update: COVID-19 related private equity activity in the pharmaceutical industry
Analysis of the key themes driving private equity deal activity reveals that COVID-19 accounted for two pharmaceutical deals announced in…
-
Q2 2024 update: electronic medical record (emr) systems related private equity activity in the pharmaceutical industry
Analysis of the key themes driving private equity deal activity reveals that electronic medical record (emr) systems accounted for 2…
-
How future of work private equity performed in the pharmaceutical industry in Q1 2024
Analysis of the key themes driving private equity deal activity reveals that future of work accounted for 3 pharmaceutical deals…
-
Private equity deals in pharmaceutical in North America decreased in Q3 2024
In the North American pharmaceutical industry, there were 27 private equity deals announced in Q3 2024, worth a total value…
-
Q1 2024 update: private equity deals in pharmaceutical in France
In the French pharmaceutical industry, there were 2 private equity deals announced in Q1 2024, worth a total value of…
-
Private equity deals in pharmaceutical in Europe decreased in Q3 2024
In the European pharmaceutical industry, there were 14 private equity deals announced in Q3 2024, worth a total value of…
-
Q3 2023 update: immuno-oncology related private equity activity in the pharmaceutical industry
Analysis of the key themes driving private equity deal activity reveals that immuno-oncology accounted for 3 pharmaceutical deals announced in…
-
Private equity deals in pharmaceutical in Asia-Pacific decreased in Q3 2024
In the Asia-Pacific pharmaceutical industry, there were 12 private equity deals announced in Q3 2024, worth a total value of…